Australian Government invests $2 million in the ‘Australian Epilepsy Research Fund’


The Epilepsy Foundation is proud to announce that the Australian Government will invest $2 million in new medical research to help find a cure for rare genetic epilepsy disorders.

This new funding will support our leading researchers to investigate genetic and other causes of epilepsy including the mutation of the Syngap gene, a rare neurological condition which can lead to epilepsy.

The SYNGAP-1 project will be the first project undertaken by the Australian Epilepsy Research Fund, and will be led by researchers from the respected Florey Institute of Neuroscience and Mental Health.

The Australian Epilepsy Research Fund has been established by the Epilepsy Foundation to provide Australians living with genetic and other types of epilepsy hope for the future through medical research.

The Australian Epilepsy Research Fund Scientific Advisory Committee is a subcommittee of the Board of the Epilepsy Foundation and will be comprised of some of Australia’s leading epilepsy experts.

More information about the Australian Epilepsy Research Fund will be released shortly.

For more information please read the “$2 million for medical research on epilepsy” media release announced by The Hon. Greg Hunt, Minister for Health, on the 26th of March 2018.

Post has no taxonomies

Comments (2)

  1. by Vanessa chang on

    I acquired Encephalitis in Jan 2017 and work up in hospital two months later cause unknown I have recently had another seizure 1.3 is later if you are still looking for people to take part in this research can you please contact me .

    1. by Fiona Waugh on

      Hi Vanessa,

      Thanks for getting in touch, and for sharing your recent experiences. Our ‘Australian Epilepsy Research Register’ is open for people who have been diagnosed with epilepsy, so please do feel free to join our research community.

      The link to join the register is –

      If you have any further questions an/or would like more support please call our Infoline on 1300 761 487.

Comments are closed.

How was your experience today?